March 14-15, 2013 | Bologna, Italy | SIOPEL group Spring Meeting



Stefano Cairo, Head of molecular biology department at XenTech, will be attending the SIOPEL group Spring Meeting.


The ultimate goal of the SIOPEL study group is to improve the prognosis and the quality of life of children affected by primary childhood liver tumors.

Primary hepatic tumours represent less than 1% of all childhood malignancies. Their frequency according to the different series is of about 0.8 – 1 case per million children less than 15 years of age per year. Hepatoblastoma (HB) is by far the most common histological subtype of primary malignant hepatic tumors occurring in children less than 15 years of age, followed by hepatocellular carcinoma (HCC).


Please contact us to meet Stefano Cairo and discuss how PDX may foster the development of new therapies for rare cancers such as hepatoblastoma